Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimensKristina Tendl-Schulz, Zsuzsanna Bagó-Horváth, Fanny Eckel et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2020Cited by 8
HER2 and HER3 expression during neoadjuvant treatment of HER2‐negative early breast cancer: potential for biomarker‐driven sequencing of T‐DXd and HER3‐DXdChristian F. Singer, Stephan Jahn, Dominik Hlauschek et al.|癌症：英文版|2025Cited by 3
Abstract P1-02-06: Prediction of Prosigna® breast cancer intrinsic subtype by immunohistochemical ER, PR and Ki67 expressionUlrike Heber, Zsuzsanna Bagó-Horváth, Kristina Tendl-Schulz et al.|Cancer Research|2022Cited by 2
Temporal Representation Learning of Phenotype Trajectories for pCR Prediction in Breast CancerIvana Janíčková, Georg Langs, Yen Y. Tan et al.|Lecture notes in computer science|2025Cited by 2
HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancerMyriam Stolz, Zsuzsanna Bagó-Horváth, Alexander Farr et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2025Cited by 1